NEW YORK (TheStreet) -- Depomed (Nasdaq:DEPO) hit a new 52-week low Tuesday as it is currently trading at $4.35, below its previous 52-week low of $4.45 with 193,829 shares traded as of 10:04 a.m. ET. Average volume has been 912,800 shares over the past 30 days. Depomed has a market cap of $273.5 million and is part of the health care sector and drugs industry. Shares are down 28.9% year to date as of the close of trading on Monday. Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. The company has a P/E ratio of 2.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Practice your DEPO trading strategies and win cash in our stock game.
Latest Headlines about DEPO
Latest from TheStreet Wire
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV